Working… Menu

HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02557854
Recruitment Status : Withdrawn (Lack of enrollment)
First Posted : September 23, 2015
Last Update Posted : March 19, 2019
Information provided by (Responsible Party):
Theodore Laetsch, University of Texas Southwestern Medical Center

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Actual Primary Completion Date : March 16, 2019
Actual Study Completion Date : March 16, 2019